Sotabase

Career

· Co-Founder & Chief Technology Officer, Diligent Robotics2017–
· PhD in Robotics, Georgia Institute of Technology2013–2018
· Intern, Honda Research Institute2013–
· Master of Science in Engineering (MSE) in Robotics, University of Pennsylvania2011–2013
· Software Engineer / Researcher, IBM Research, Almaden2009–2011
· Bachelor of Science (BS) in Electrical Engineering and Computer Science, University of California, Berkeley2005–2009

Publications (143)

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.
Archives of Internal Medicine · 2009
2,191
cited
Early Predictors of In-Hospital Death in Infective Endocarditis
Circulation · 2004
408
cited
Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999.
American Heart Journal · 2004
397
cited
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.
Clinical Infectious Diseases · 2007
336
cited
Management Considerations in Infective Endocarditis: A Review
Journal of the American Medical Association (JAMA) · 2018
307
cited
Analysis of the Impact of Early Surgery on In-Hospital Mortality of Native Valve Endocarditis: Use of Propensity Score and Instrumental Variable Methods to Adjust for Treatment-Selection Bias
Circulation · 2010
290
cited
Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices.
Journal of the American Medical Association (JAMA) · 2012
289
cited
Non-HACEK Gram-Negative Bacillus Endocarditis
Annals of Internal Medicine · 2007
253
cited
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis.
JAMA Internal Medicine · 2013
248
cited
HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort
PLoS ONE · 2013
216
cited
Early surgery in patients with infective endocarditis: a propensity score analysis.
Clinical Infectious Diseases · 2007
213
cited
Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature.
Global Heart · 2014
195
cited
Candida infective endocarditis
European Journal of Clinical Microbiology and Infectious Diseases · 2008
193
cited
Original Contribution Association between Valvular Surgery and Mortality among Patients with Infective Endocarditis Complicated by Heart Failure
184
cited
Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis.
Clinical Infectious Diseases · 2008
179
cited
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
Clinical Infectious Diseases · 2005
170
cited
Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study
Antimicrobial Agents and Chemotherapy · 2006
163
cited
Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · 2016
158
cited
Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.
Clinical Microbiology and Infection · 2013
153
cited
Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes.
American Journal of Medicine · 2005
153
cited
Sotabase
Vivian Chu | Researcher Profile | Sotabase | Sotabase